Literature DB >> 6933478

Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction.

C A Rouzer, W A Scott, J Kempe, Z A Cohn.   

Abstract

The ingestion of particles by macrophages leads to the prompt induction of prostaglandin (PG) synthesis. We have now dissected the endocytic process and examined the requirements of prostaglandin E (PGE) synthesis for particle attachment, membrane interiorization, and phagosome-lysosome fusion. Macrophages that were loaded with the polyanion dextran sulfate and exhibited a greater than 99% inhibition of phagosome-lysosome fusion produced normal amounts of PGE upon challenge with zymosan. Inhibition of membrane interiorization with cytochalasin D was similarly ineffective in blocking PGE synthesis. The addition of large numbers of unmodified polystyrene latex beads, which were readily ingested by macrophages, failed to stimulate PGE synthesis. However, when macrophages were challenged with latex beads coated with immune complexes, an increased synthesis of PGE resulted. No response occurred if the complex was prepared with the F(ab')2 fragment of IgG. Similar results occurred when nonphagocytizable Sephadex beads coated with immune complexes were employed. We conclude that particle binding to the Fc receptor of the macrophage plasma membrane is a sufficient stimulus for PGE synthesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933478      PMCID: PMC349816          DOI: 10.1073/pnas.77.7.4279

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Macrophages on intrauterine contraceptive devices produce prostaglandins.

Authors:  L Myatt; M A Bray; D Gordon; J Morley
Journal:  Nature       Date:  1975-09-18       Impact factor: 49.962

Review 2.  Endocytosis.

Authors:  S C Silverstein; R M Steinman; Z A Cohn
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Studies on the immunoglobulins which stimulate the ingestion of glutaraldehyde-treated red cells attached to macrophages.

Authors:  M Rabinovitch
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

4.  Significance of phospholipase A for prostaglandin formation.

Authors:  H Kunze; W Vogt
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

5.  Interference with normal phagosome-lysosome fusion in macrophages, using ingested yeast cells and suramin.

Authors:  P D Hart; M R Young
Journal:  Nature       Date:  1975-07-03       Impact factor: 49.962

6.  Extraction of prostaglandins from human blood.

Authors:  W G Unger; I F Stamford; A Bennett
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

7.  Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands.

Authors:  F J Van der Ouderaa; M Buytenhek; D H Nugteren; D A Van Dorp
Journal:  Biochim Biophys Acta       Date:  1977-05-25

8.  Membrane flow during pinocytosis. A stereologic analysis.

Authors:  R M Steinman; S E Brodie; Z A Cohn
Journal:  J Cell Biol       Date:  1976-03       Impact factor: 10.539

9.  The presence of two Fc receptors on mouse macrophages: evidence from a variant cell line and differential trypsin sensitivity.

Authors:  J C Unkeless
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

10.  Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.

Authors:  F M Griffin; C Bianco; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  47 in total

1.  Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin E2 in the perfused rat liver.

Authors:  D B Buxton; R A Fisher; D L Briseno; D J Hanahan; M S Olson
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies.

Authors:  M S Chappel; D E Isenman; M Everett; Y Y Xu; K J Dorrington; M H Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  Properties of solubilized Fc gamma-receptors from psoriatic scales.

Authors:  J K Livden; E K Kristoffersen; R Matre
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

4.  Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.

Authors:  R D Bigler; M Khoo; S Lund-Katz; L Scerbo; M Esfahani
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Presentation by peritoneal macrophages: modulation by antibody-antigen complexes.

Authors:  K A Perkins; B M Chain
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

6.  Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.

Authors:  A Dulioust; E Vivier; N Meslier; R Roubin; I Haye-Legrand; J Benveniste
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

7.  Effects of prostaglandins E1, E2, and F2 alpha on N-acetyl-beta-glucosaminidase activities of human synovial cells in culture.

Authors:  B J Clarris; L P Malcolm
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

8.  Phospholipid Ozonation Products Activate the 5-Lipoxygenase Pathway in Macrophages.

Authors:  Karin A Zemski Berry; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2016-08-03       Impact factor: 3.739

9.  Human alveolar macrophages produce leukotriene B4.

Authors:  A O Fels; N A Pawlowski; E B Cramer; T K King; Z A Cohn; W A Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures.

Authors:  N A Pawlowski; G Kaplan; A L Hamill; Z A Cohn; W A Scott
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.